NEW YORK, April 16 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, reported today that the company's Chairman and CEO, Jack Kachkar, M.D., reaffirmed to the special committee of the Inyx board of directors his all-cash offer priced at $3.01 per share to take the company private that was originally announced on March 26, 2007. The special committee, with the assistance of an independent investment- banking firm it has selected, is in the process of evaluating the fairness of the going-private offer. It expects to complete its evaluation after the company reports its audited operating results for 2006. The special committee will then issue a recommendation to Inyx stockholders, who will be asked to vote on the offer. The $3.01 per share offer, which matches the all-time-high closing price for Inyx's common stock recorded on March 23, 2006, has the support of Inyx's entire senior management team, which is participating in the offer along with a strategic outside financial investor. About Inyx Inyx, Inc. is a specialty pharmaceutical company with niche drug-delivery technologies and products for the treatment of respiratory, allergy, dermatological, topical, cardiovascular and pain-management conditions. Inyx focuses its expertise on both prescription and over-the-counter pharmaceutical products, and provides specialty pharmaceutical development and production consulting services. In addition, Inyx is developing its own proprietary products. The company's operations are conducted through several wholly owned subsidiaries: Inyx USA Ltd., based in Manati, Puerto Rico; Inyx Pharma Ltd. and Inyx Europe Limited, which owns and operates Ashton Pharmaceuticals Ltd., all near Manchester, England; Inyx Canada, Inc. in Toronto; and Exaeris, Inc., based in Exton, Pennsylvania, which conducts Inyx's marketing and distribution activities. Inyx, Inc.'s corporate offices are in New York City. For more information, please visit: http://www.inyxgroup.com/ . Safe Harbor Statements about the Inyx's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. Inyx intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, Inyx's actual results could differ materially from expected results. For more information, please contact: Jay M. Green, Executive VP, 212-838-1111 Bill Kelly, VP-IR, 212-838-1111 DATASOURCE: Inyx, Inc. CONTACT: Jay M. Green, Executive VP, +1-212-838-1111, , Bill Kelly, VP-IR, +1-212-838-1111, , both of Inyx, Inc. Web site: http://www.inyxinc.com/

Copyright